# ðŸš€ Nishant Thalwal
**Bridging Life Science Intelligence & Business Strategy** *M.S. Life Science Informatics | B.Tech Biotechnology*

[LinkedIn](your-linkedin-url) â€¢ [Email](mailto:your-university-email) â€¢ [Portfolio](#)

---

### ðŸŽ¯ The Mission
I translate **scientific uncertainty into business clarity**. With a foundation in biotechnology and data informatics, I build frameworks to answer the most critical question in pharma and biotech: **"What should the company do next?"**

I am transitioning from technical execution to **decision-facing roles** in consulting, portfolio strategy, and market access.

---

### ðŸ› ï¸ Strategic Toolkit

| **Analytical Reasoning** | **Business & Strategy** | **Technical Stack** |
| :--- | :--- | :--- |
| MECE Problem Structuring | R&D Portfolio Prioritization | SQL & Python (Data Logic) |
| Decision Trees & Trade-offs | Drug Development Economics | Excel (Financial Modeling) |
| Risk-Adjusted Value Models | Market Access & Reimbursement | PowerPoint (Exec Comms) |

---

### ðŸ§ª Focus Areas
* **Consulting & Strategy:** Navigating complex pharma landscapes and competitive dynamics.
* **Capital Allocation:** Optimizing R&D spend across therapeutic areas under clinical uncertainty.
* **Regulatory Logic:** Aligning scientific development with market access and reimbursement constraints.
* **Decision Frameworks:** Building models where the **decision** dictates the **execution**, not the other way around.

---

### ðŸ“‚ High-Impact Projects
* **Clinical Portfolio Prioritization:** Quantitative models to rank R&D assets based on probability of success ($PoS$) and $NPV$.
* **Pharma Landscape Analysis:** Competitive intelligence briefs for specific therapeutic areas.
* **Decision Briefs:** Translating complex biological data into actionable executive recommendations.
* **Healthcare Economics:** Case studies on market entry and reimbursement pathways (AMNOG/EMA/FDA).

---

### ðŸ¤ Letâ€™s Collaborate
I am actively seeking opportunities to contribute to:
* Life-science strategy or consulting case studies.
* Pharma/Biotech decision-analysis projects.
* Market access and health-econ modeling.

> **Fun Fact:** Iâ€™m intentionally moving away from the "wet lab" and "routine pipelines" to focus on the high-stakes decisions that determine if a drug ever reaches a patient.

---

### ðŸŽ“ Background Summary
* **M.S. Life Science Informatics** â€“ Germany (Current)
* **B.Tech Biotechnology** â€“ India
* **Focus:** Transitioning from data execution to **Strategic Decision Support**.
